ABsTRAc-r Neuropeptide tyrosine (NPY), a newly discovered peptide known to modulate blood vessel diameter and smooth muscle tone, has been found in many mammalian organs. Its distribution is similar to that of sympathetic nerve fibres and NPY immunoreactivity has been found in noradrenergic ganglion cells. In a study of the respiratory tract of four mammalian species-man, cat, guinea pig, and rat-NPY immunoreactivity has been localised to nerve fibres. NPY immunoreactive nerve fibres were found in the adventitia of blood vessels and in the airway smooth muscle. Its distribution was strikingly similar to that of sympathetic nerve fibres as demonstrated by dopamine-,8-hydroxylase antibodies. The mean (SD) concentrations of NPY in the guinea pig respiratory tract, as determined by radioimmunoassay of tissue extracts, were: upper trachea 3*3 (0.7), lower trachea 2'0 (0.5), and major bronchus 3-5 (1.1) pmol/g. During developmental studies in man NPY immunoreactive nerve fibres were first observed at 20 weeks' gestation in the trachea, and fibres gradually extended down into the intrapulmonary airways after birth. NPY immunoreactive nerve fibres have a distribution and developmental pattern similar to that of sympathetic nerve fibres in the respiratory tract. The finding of NPY immunoreactivity in nerve fibres in the mammalian respiratory tract adds to the growing number of peptides having potent biological actions found in this organ, and shows that the lung possesses a rich peptidergic system, which may influence pulmonary function.
ABsTRAc-r Neuropeptide tyrosine (NPY), a newly discovered peptide known to modulate blood vessel diameter and smooth muscle tone, has been found in many mammalian organs. Its distribution is similar to that of sympathetic nerve fibres and NPY immunoreactivity has been found in noradrenergic ganglion cells. In a study of the respiratory tract of four mammalian species-man, cat, guinea pig, and rat-NPY immunoreactivity has been localised to nerve fibres. NPY immunoreactive nerve fibres were found in the adventitia of blood vessels and in the airway smooth muscle. Its distribution was strikingly similar to that of sympathetic nerve fibres as demonstrated by dopamine-,8-hydroxylase antibodies. The mean (SD) concentrations of NPY in the guinea pig respiratory tract, as determined by radioimmunoassay of tissue extracts, were: upper trachea 3*3 (0.7), lower trachea 2'0 (0.5), and major bronchus 3-5 (1.1) pmol/g. During developmental studies in man NPY immunoreactive nerve fibres were first observed at 20 
Methods
Respiratory tissue was obtained from 15 human adults (seven male and eight female, aged 18-88 years) dying of non-cardiopulmonary causes, obtained within 12-18 hours of death. In each case, the areas dissected out included the trachea and major bronchi, the inner lung zone containing minor bronchi, the middle lung zone containing medium sized bronchi, and the outer lung zone including alveoli. Areas similar to those dissected out of the adult human respiratory tract were also obtained from 11 adult cats (five female and six male, 2 9-4 2 kg, aged 15-24 months), eight Wistar rats (all female, 190-250 g, aged 3-4 months), and six Dunkin Hartley guinea pigs (four male and two female, 250-450 g, aged 4-6 months). The animals were killed by cervical dislocation (rat and guinea pig) or with an intraperitoneal injection of sodium pentobarbitone (cat).
For developmental studies, the respiratory tract was taken from fresh human abortuses (less than 6 hours old), whose gestational age was estimated by foot length in dismembered fetuses'8 and crownrump length in intact fetuses.'9 The fetuses were divided into two groups on the basis of gestational age and stage of lung development:20 7-16 weeks (glandular stage; n = 19) and 17-24 weeks (canalicular stage; n = 11). Respiratory tissue was also obtained from human neonates (n = 9) and infants aged from 6 weeks to 6 years (n = 4) dying of non-cardiopulmonary causes. In the fetal respiratory tract the areas dissected out included trachea, major bronchi, and inner and outer lung zones. In the postnatal specimens the areas dissected out were similar to those of the human adult. Each specimen of respiratory tract from all four species was subdivided and processed for immunocytochemistry and radioimmunoassay.
IMMUNOCYTOCHEMISTRY
Fixation Each piece of respiratory tract, measuring 1 x 0-75 x 0-5 cm, from all four species was processed as follows. Fresh tissue was fixed in parabenzoquinone solution (0.4 g benzoquinone: 100 ml 0-01 molI phosphate buffered saline (PBS), pH 7.4) for one and a half hours at 4°C.2' After fixation the tissue was washed overnight in buffered sucrose (70 mg/ml sucrose, 0 1 mg/ml sodium azide in PBS) and then made into cryostat blocks and sectioned at a thickness of 10 ,um in a cryostat at -20°C. Technique The indirect immunofluorescence technique22 was applied to the sections, antibodies to natural porcine NPY conjugated to bovine serum albumin with bis-diazobenzidine being used. NPY antibodies were used at a dilution of 1:600. Preabsorption of the antiserum with pure or synthetic NPY at a concentration of 1-0 nmol/ml of diluted antibody completely abolished immunostaining, whereas the addition of pure or synthetic PYY, PP, VIP, or substance P at concentrations above 30 nmol/ml of diluted antibodies had no effect on the immunostaining. Antibodies to dopamine-f3-hydroxylase were kindly provided by Dr RA Rush of Flinders Medical School, Australia, and used at a dilution of 1:2000. Negative controls included normal rabbit serum at a dilution of 1:2000 and fluorescein-isothiocyanate conjugate (FITC) alone.
RADIOIMMUNOASSAY
For radioimmunoassay, the NPY content of guinea pig respiratory tract was extracted by boiling weighed tissue in 0-5 mol/l acetic acid (10% w/v). NPY concentrations in these extracts were determined with an antibody (YNI) raised in rabbit to natural porcine NPY conjugated to bovine serum albumin with carbodiimide. Natural porcine NPY was iodinated by chloramine T oxidation and purified on a G50 superfine column before use as tracer in the assay. The antibody was used in a final dilution of 1:10 000 in an assay volume of 600 IlI 0-06 mmol/I sodium phosphate buffer, pH 7-2, containing 1 % bovine serum albumin. Twenty microlitre aliquots of extracts were assayed in duplicate. Pure porcine NPY was used as standard. The assay could detect 2 fmol per assay tube with 95% confidence.
Results

IMMUNOCYTOCHEMISTRY
NPY-like immunoreactive nerves were seen throughout the adult respiratory tract of all four species studied. Fine varicose fibres were located chiefly in the adventitia of tracheobronchial and pulmonary blood vessels, both arteries and veins, down to the level of the capillaries (fig 1) . NPY immunoreactive fibres were also seen in the airway smooth muscle from the trachea down to the level of the bronchioles (fig 2) , but diminished in density towards the bronchioles. Although ganglion cells were present in the respiratory tract of all species, particularly in the adventitia of the tracheobronchial wall, none of these ganglion cells was immunoreactive for NPY. D,8H immunoreactive nerve fibres have a strikingly similar distribution to NPY containing nerve fibres, being located chiefly around blood vessles and in airway smooth muscle (figs 3 and 4).
In the human fetal respiratory tract NPY Sheppard, Polak, Allen, Bloom immunoreactive nerve fibres were first observed in the smooth muscle and blood vessels of the trachea and major bronchi at 20 weeks' gestation (late canalicular stage). After birth NPY containing nerve fibres extended into the intrapulmonary airways and blood vessels and their distribution was similar to that in the adult. Interestingly, D,JH immunoreactive nerve fibres were also first observed at 20 weeks and followed a developmental pattern similar to that of NPY containing nerve fibres.
RADIOIMMUNOASSAY
The highest concentrations of extractable NPY were found in the upper trachea (3.3 (SD 0.7) pmol/g) and major bronchi (3-5 (1-1) pmol/g), whereas lower concentrations were identified in the lower trachea (2.0 (0.5) pmol/g) and middle lung (1.2 (0-5) pmollg). NPY concentrations were below the detection limit of the assay (that is, <0.5 pmollg) in the nasal mucosa, inner lung, and outer lung.
Discussion
The results show that the newly isolated peptide NPY is present in the adult mammalian respiratory tract. The localisation of NPY immunoreactivity to nerve fibres around blood vessels and smooth muscle in the respiratory tract is interesting in view of the known actions of this peptide. NPY is a potent vasoconstrictor in the cat' 7 and in the rabbit heart NPY reduces myocardial perfusion and inhibits the force of myocardial contraction. 
